We present Post-Acquisition Targeted Searches (PATS), an easy-to-use tool that allows the identification of novel peptide/protein sequences from existing big mass spectrometry data sets. PATS filters out the unrelated peptidome before the time-consuming database search to significantly speed up the identification. Using interactome data sets, PATS visualizes protein interaction network and helps to assign putative functions to the target protein based on the "guilt by association" concept.
Protein identification generally consists of matching tandem mass spectrometry data to sequences in a database derived from DNA sequencing of an organism's genome 1 . The protein database is dependent on our ability to predict open reading frames (ORFs) and, as a result, could be incomplete. Indeed, new techniques such as ribosome profiling and proteogenomics have revealed the existence of additional ORFs that are overlooked by traditional ORF-finding algorithms 2 . The existence of these non-annotated ORFs creates a new challenge to understand the biological functions of these proteins [3] [4] [5] .
Theoretically, large-scale mass spectrometry data from proteomic studies could be used to help assess the functions of additional proteins through data mining. For example, two maps of the human proteome 6, 7 and several large-scale protein-protein interactome studies [8] [9] [10] are the types of big data sets that could be used for data mining. However, the mass spectrometry data collected in these types of studies is often not exhaustively analyzed to identify all possible peptide sequences or modified peptides, and thus they constitute a potential resource to identify new information or to verify sequences obtained in other kinds of experiments. To mine these data sets, we must be able to perform searches with the newly discovered ORFs, peptides, or proteins.
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The sheer size of the data and the huge computational complexity of these data sets makes this a daunting task. Here we present Post-Acquisition Targeted Searches (PATS), a search tool that allows researchers without extensive proteomics knowledge and large computational resources to rapidly identify novel peptide and protein sequences in large published mass spectrometry data sets (>terabytes). With two of the largest interactome studies pre-loaded (5 terabytes of raw mass spectrometry data in total), PATS automatically visualizes protein correlation matrixes and protein network maps for all the bait proteins of each searched peptide sequence (e.g. Figure 2a b), provides readily testable hypotheses for protein function based on the "guilt by association" concept".
The intent of the method is to provide an effective means to determine if a unique sequence (or other sequences), with or without PTMs, is present in large mass spectrometry data sets. In contrast to existing targeted strategies such as "peptide-centric proteome analysis" 11, 12 and "targeted database analysis" 13 PATS is available online at http://sequest.scripps.edu/PATS with two of the largest interactome mass spectrometry data sets pre-loaded (5 terabytes of raw mass spectrometry data in total). To search any specific peptide with or without PTM within these two data sets, user can simply submit their peptide sequence of interest to PATS and the result will be automatically generated (e.g. Figure 2a -b). For more advanced usage, the source code as well as a detailed instruction of how to run PATS on custom data set is available at https://github.com/bathyg/PATS/. To speed a search, PATS uses three methods for data reduction (Figure 1a , Supplementary Figure 1 ). In the first step, low-quality spectra that often result in unreliable peptide spectrum match (PSM) were eliminated. Any spectrum containing less than 20 peaks or with an average peak signal-to-noise ratio (SNR) less than 2.0 was excluded. In the second step, MS/MS data was filtered by the precursor ion m/z value of each spectrum. A precursor ion m/z value candidate list was generated for the target peptide, providing all possible charge states of the precursor ion. Spectra with precursor ion m/z values outside of the candidate list were excluded immediately and no longer processed. In the final step, comparing the theoretical fragment ions of the target peptide to each spectrum filtered all the remaining spectra. To do this a fragment ion list containing all b and y ions was calculated for each input peptide sequence and then at least five b or y ions have to match within 100 ppm of the fragment ion masses. After these three data reduction stages, the remaining tandem mass spectra are searched against the desired database. To illustrate the process performed by PATS, a tryptic peptide sequence from the Krüppel associated box (KRAB) domain, 'DVMLENYR', was used as a peptide of interest and searched within a human interactome data set that consists of 4,293 AP-MS experiments containing more than 69 million spectra. When directly searched with a conventional search method using a reference protein database (Uniprot 2017-01, human, both reviewed and unreviewed), the search costs more than 40,000 CPU-hours (defined as total running hours × number of cores per CPU) to identify 19,521,327 peptide-spectrum matches (PSMs), of which 332 PSMs were related to 6/17 peptide sequence 'DVMLENYR' (Table 1 ). Next, we used PATS with the same target peptide and database. The whole data set was filtered through PATS and then searched with equivalent parameters. The first step assesses the quality of tandem mass spectra and eliminates poor quality spectra. Of the 69 million spectra in the data set, 91% or 63 million pass the quality test ( Figure   1b ). The second step of filtering using precursor ion filter reduces the number of spectra to 32,904. Finally, in the third step, the number of spectra was further reduced to 8,452 spectra by matching predicted b and y ions. PATS required a total of 3 minutes 15 seconds to reduce 69 million spectra to 8,452. Then, when searched with a conventional algorithm against the same protein reference database with equivalent parameters, we identified 5,216 peptide-spectrum matches (PSMs) from PATS filtered data (8,452 spectra). From the 5,216 PSMs identified, we found the exact same 332 PSMs related to peptide sequence 'DVMLENYR' that was found with the conventional method. Overall, the search took less than 1 CPU-hour and obtained the same result as the conventional database search for peptide 'DVMLENYR', a speed increase of approximately 40,000-fold. This result showed that PATS filtered data were specifically enriched, from 0.0017% to 6.4% of total PSMs (3,765-fold enrichment), for our peptide of interest 'DVMLENYR' (Table 1 ) and therefore improved search efficiency. One application of PATS is to identify protein-protein interactions for proteins from previously non-annotated ORFs. In particular, the use of proteogenomics has uncovered the existence of hundreds to thousands of non-annotated microproteins derived from small ORFs (smORFs) in genomes from organisms ranging from yeast to humans. To date, the functions of almost of all of these proteins still remains a mystery. Determining if the products of these microproteins are functional is a difficult challenge and simply testing possible functions without a starting point is costly (e.g., large-scale screens). Instead, if some preliminary functional biochemical data could be obtained for these smORFs, it should be possible develop reasonable hypotheses that could speed their functional characterization.
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A means to help assign putative functions to proteins is the "guilt by association" paradigm, which argues if a protein of unknown function interacts with a protein of known function then that protein's function should be related 14 . The identification of microprotein-protein interactions has proven to be a successful approach for characterizing novel microproteins in a few cases. For example, the identification of protein-binding partners of a microprotein called NoBody revealed a role for this protein in modulating mRNA decapping 4 . To perform and search thousands of immunoprecipitation experiments to characterize microproteins is a daunting task and consequently PATS can be used to accelerate this process. To test the ability of the method to identify new biological information for small ORF encoded microproteins (SEP, sequence < 150 amino acids) in a large interactome, we searched 365 microproteins that had been previously identified by shotgun proteomics [15] [16] [17] . We first constructed a protein sequence database by appending the protein sequence of 365 microproteins (see Supplementary Table 1) Table 2 ). We then compared the results from both conventional search and PATS search. As shown in In this human interactome MS/MS data set, each raw data file represents an AP-MS pulldown experiment from HeLa cell lysate by a specific bait protein 10 . Proteins identified from a specific AP-MS experiment represent all interactors of the bait protein, either specific or nonspecific (e.g. noise). Within all the identified microproteins, many were identified from multiple AP-MS experiments of several bait proteins. We noted that many of the bait proteins belong to the same protein family or have close connections. Therefore, it would be interesting to see if these potential interactors of each microprotein interact with each other and form protein interaction network. PATS automatically generated protein correlation matrixes of the bait proteins using STRING-DB (string-db.org) correlation score (Figure 2a. ) and K-mean clustering algorithm. From the correlation matrix and the confidence of peptide identification, PATS then generated an interactive protein network representing all the bait proteins that interact with the target protein/peptide. (Figure 2b .) The size of each node represents identification confidence and the color represents identification frequency (total spectral count) in the whole data set. The
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thickness of edges between nodes represents the STRING-DB correlation between two proteins.
As shown in Figure 2b , there were three distinct protein clusters. The one with most highly confident proteins and interactions was the RUVBL1-PFDN2-RUBVL2 cluster. In order to further validate this interaction, we custom synthesized 18 synthetic peptides and compared their MS/MS with the ones identified by PATS. Most of the synthetic peptides showed almost identical fragmentation pattern with the ones identified by PATS ( Supplementary Spectra 1-18) ,
showing peptide level evidence of the existence of these detected microproteins. 
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With these data in hand, we went on and validated the results of the identification for some microprotein-protein interactions using immunoprecipitation against FLAG epitope. We transiently transfected HEK293T cells with FLAG-tagged SEP365 (see Supplementary Table 1 for microprotein name and sequence used in this study) or empty vector and APEX-FLAGtagged SEP215 or APEX-FLAG only vector. The anti-FLAG immunoprecipitates from cell lysates were analyzed by Western blot to quantify proteins specifically enriched over a vector only or APEX-FLAG immunoprecipitation control. SEP365 was one of the top hits in PATS, also recently reported to be involved in mRNA decapping complex 4 . The Western blot showed a consistent result where EDC4, a member of mRNA decapping complex, was enriched in SEP365-FLAG immunoprecipitation (Figure 2c ). PATS identified SEP215 to be associated with RUVBL1/2 and PFDN2 protein complex with high confidence. We performed immunoprecipitation and blotted against both PFDN2 and RUVBL1. We identified that PFDN2
as a potential direct interactor as shown by strong enrichment of PFDN2 in a Western blot, however we did not detect enrichment of RUVBL1 (Figure 2c ). This may suggest that SEP215 has strong association with RUVBL1/2 in a protein complex but does not directly bind. Currently, PATS is preloaded with two of the largest human protein interaction data sets [8] [9] [10] and can be used freely at http://sequenst.scripps.edu/PATS. We hope to include interactome data sets from other human cell lines as well as other species in the near future. Western blot
ACKNOWLEDGMENTS
